OncoSec Medical Incorporated (ONCSQ)

OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Dec 30, 2025
Market Cap6.00
Revenue (ttm)n/a
Net Income (ttm)-29.39M
Shares Out5.96M
EPS (ttm)-14.77
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume2,045
Average Volume25,540
Open0.0000
Previous Close0.0000
Day's Range0.0000 - 0.0000
52-Week Range0.0000 - 0.0001
Beta10.38
RSI47.45
Earnings Daten/a

About OncoSec Medical

OncoSec Medical Incorporated, a late-stage immuno-oncology company, focuses on designing, developing, commercializing intra-tumoral DNA-based therapeutics to stimulate and augment anti-tumor immune responses for the treatment of cancer. The company’s product pipeline includes KEYNOTE-695, which is in Phase 2 trial for the treatment of advanced melanoma; TAVO + SARS-CoV-2 spike glycoprotein, which is in Phase 1 clinical trial for the treatment of COVID-19; and TAVO + epacadostat + pembrolizumab, which is in Phase 1 clinical trial for the treatme... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2008
Employees 41
Stock Exchange OTCMKTS
Ticker Symbol ONCSQ
Full Company Profile

Financial Performance

Financial Statements